JP Patent

JP2016020366A — Ｃｏｍｔ阻害剤

Assigned to NOVIPHARMA SA · Expires 2016-02-04 · 10y expired

What this patent protects

【課題】ある種の中枢及び末梢神経系疾患の治療において有用なＣＯＭＴ阻害剤の提供。【解決手段】式Ｉで表される化合物。（Ｒ1及びＲ2はH等；Ｘはメチレン；Ｙは酸素等；ｎ、ｍは０，１等；Ｒ3はピリジンＮ−オキシド）【選択図】なし

USPTO Abstract

【課題】ある種の中枢及び末梢神経系疾患の治療において有用なＣＯＭＴ阻害剤の提供。【解決手段】式Ｉで表される化合物。（Ｒ1及びＲ2はH等；Ｘはメチレン；Ｙは酸素等；ｎ、ｍは０，１等；Ｒ3はピリジンＮ−オキシド）【選択図】なし

Drugs covered by this patent

Patent Metadata

Patent number: JP2016020366A
Jurisdiction: JP
Classification: —
Expires: 2016-02-04
Drug substance claim: No
Drug product claim: No
Assignee: NOVIPHARMA SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.